Pictet Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3M Sell
923,696
-44,920
-5% -$1.22M 0.03% 416
2025
Q4
$26.3M Sell
968,616
-243,374
-20% -$6.41M 0.03% 462
2025
Q3
$31.4M Sell
1,211,990
-88,339
-7% -$2.05M 0.03% 423
2025
Q2
$26.5M Buy
1,300,329
+342,535
+36% +$6.67M 0.03% 437
2025
Q1
$17.4M Sell
957,794
-132,379
-12% -$2.96M 0.02% 531
2024
Q4
$27.5M Sell
1,090,173
-48,273
-4% -$1.31M 0.03% 417
2024
Q3
$38.7M Sell
1,138,446
-245,234
-18% -$9.34M 0.04% 339
2024
Q2
$51.2M Sell
1,383,680
-111,275
-7% -$4.2M 0.06% 278
2024
Q1
$62.7M Sell
1,494,955
-730,493
-33% -$30M 0.07% 269
2023
Q4
$88.3M Buy
2,225,448
+374,478
+20% +$11M 0.1% 217
2023
Q3
$50.9M Buy
+1,850,970
New +$58M 0.06% 284

Other funds holding CLDX